Welcome to our dedicated page for BRASKEM SA SEC filings (Ticker: BAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BRASKEM SA's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BRASKEM SA's regulatory disclosures and financial reporting.
Braskem S.A. (NYSE: BAK) disclosed that controlling shareholder Novonor and potential buyer Petroquímica Verde FIP have formally notified Brazil’s antitrust authority (CADE) to seek approval for a possible transfer of Novonor’s stake held through NSP Investimentos. The filing is an early but necessary step toward a transaction first flagged on May 23, 2025.
The companies emphasize that no binding agreement has yet been signed. Completion remains contingent on (i) CADE clearance, (ii) Novonor’s compliance with its shareholders-agreement obligations to Petrobras, and (iii) successful negotiations with creditor banks that currently hold fiduciary liens on Novonor’s Braskem shares. Management provided no financial terms or timeline.
- The move could reshape Braskem’s ownership structure, potentially easing Novonor’s financial distress and introducing a new strategic partner.
- However, multiple approvals and creditor negotiations create execution risk and timing uncertainty.
Braskem S.A. (NYSE:BAK) filed a Form 6-K reporting the minutes of its Board of Directors meeting held on 26 June 2025.
- Key action: The Board unanimously elected Mr. Nir Lander as a Statutory Officer (without specific designation) effective 1 July 2025, replacing Mr. André Amaro.
- Term: Mr. Lander will serve until the first Board meeting following the 2027 Ordinary General Meeting.
- Governance compliance: The new officer provided all declarations required under Brazilian Corporation Law and CVM Resolutions 44 and 80, confirming no legal impediments.
- Board composition (from 1 July 2025):
- Roberto Prisco Paraiso Ramos – CEO
- Felipe Montoro Jens – CFO & IRO
- Stefan Lanna Lepecki – Director
- Nir Lander – Director
- Geraldo Magela de Moraes Vilaça Netto – Director
No other subjects were recorded, and the meeting was adjourned without additional matters.